Reading time: 4 minutes Sydney Scatigno Over the last couple of decades, cancer research has made strides in improving the pre-clinical assessment of novel compounds. Compound screening, the process of assessing new compounds for efficacy, across various cell lines is an important step in finding the optimal drug candidate downstream in the drug development process.... Continue Reading →
Colette Bilynsky CAR-T cell therapy is widely available in the United States, with 6 FDA-approved formulations, and has been previously discussed on Oncobites. However, a new clinical trial using the CAR (chimeric antigen receptor) technology is underway, but using macrophages instead of T-Cells in the hope of treating more types of cancer. But let’s take... Continue Reading →
Reading time: 4 minutes Megan Majocha Breast cancer is the most common cancer and it is the second leading cause of cancer-related deaths among women in the United States1. Women with breast cancer have a 5-year survival rate of 99% if the tumor remains localized in the breast, but survival drops to 30% if women... Continue Reading →
OncoBites 